Latest Releases
Senators Smith, Grassley Introduce Bipartisan Bills to Help Students Navigate College Costs
WASHINGTON [2.27.23] – Today, Senators Tina Smith (D-Minn.) and Chuck Grassley (R-Iowa) reintroduced three bipartisan bills to help students and families make informed decisions about borrowing for college. The bills ensure that students get the full picture when choosing a college and taking out loans. From the initial college search, to the acceptance of financial aid, to counseling once in college, the bills would help college students avoid sticker shock, find the best college for their budget and avoid taking out ill-advised and oversized loans. In December 2022, the Government Accountability Office issued an alarming report, finding that colleges are misleading students, understating costs and leaving out critical details regarding federal student aid. “We need to equip students and their families with better information about the costs of college from the initial college search to when they receive financial aid offers. My bipartisan bills with Sens. Grassley and Ernst would help fix these problems,” said Smith. “That includes improved net price calculators so students and families have estimates of college costs after taking into account scholarships and grants. We’ve got a plan to create a universal financial aid offer so students can easily compare financial aid packages between schools, which is important because time and again students are met with inconsistent and incomplete information. And we’ve introduced a bill to improve loan counseling. These reforms will help students make one of the biggest financial decisions of their lives—how to pay for college.” “I often hear from Iowa families who are frustrated
U.S. Senators Smith, Murkowski, Hassan Reintroduce Bipartisan Bill to Expand Mental Health Care Workforce
WASHINGTON [2.23.23] – Today, U.S. Senators Tina Smith (D-MN), Lisa Murkowski (R-AK), and Maggie Hassan (D-NH) reintroduced their bipartisan legislation to strengthen the mental health workforce in the face of shortages. The Mental Health Professionals Workforce Shortage Loan Repayment Act would repay up to $250,000 in eligible student loan repayment for mental health professionals who work in mental health professional shortage areas. Sen. Smith has shared her own mental health journey from the Senate floor—and again in an op-ed last week in the wake of news that Senator John Fetterman (D-PA) was seeking treatment for depression —in hopes of breaking the stigma around mental health and working to expand access so Americans get the help they need. “I’ve shared my own story with depression because I want anyone suffering from a mental health issue to know they are not alone. We can all help break the stigma around talking about this, but de-stigmatizing and de-mystifying mental illness is just the beginning. We have to make sure mental health resources are available to everyone,” said Sen. Smith, a member of the Senate Health Committee. “We need to pass our bipartisan bill to help close the holes in the net we build to catch people when they fall and need help.” “Alaska continues to be disproportionally impacted by mental health and substance use disorders; and across the nation, mental and behavioral health workforce shortages are critically affecting access to care. This is especially true in rural communities,” said Sen. Murkowski. “Building on
Sens. Smith, Warren Raise Questions about Accuracy of Secretary Azar’s Testimony Blaming Pharmacy Benefit Managers for High Drug Prices
WASHINGTON, DC [08/17/18]—Today, U.S. Sens. Tina Smith (D-Minn.) and Elizabeth Warren (D-Mass.) questioned Health and Human Services (HHS) Secretary Alex Azar about his potentially misleading statements during his Senate testimony in which he blamed pharmacy benefit managers (PBMs) and drug distributors for drug manufacturers’ ongoing refusal to meaningfully reduce drug prices. The senators’ letter follows new information obtained from PBMs and drug distributors that directly contradicts the allegations made by Secretary Azar and raises questions about the accuracy of his testimony to Congress. Despite President Trump’s promises that drug companies would voluntarily enact “massive” price cuts, there have been no significant drug price
U.S. Sens. Tina Smith, Amy Klobuchar Honor the Storied Life of Minnesota’s First Female Member of Congress, Coya Knutson, with Senate Resolution
MINNESOTA [08/22/18]— Today, Minnesota’s U.S. Sens. Tina Smith and Amy Klobuchar honored the storied life of Minnesota’s first female member Congress, Coya Knutson, with a Senate Resolution heralding her life as a trailblazer who, despite great obstacles when she served in the 1950s, succeeded in making a difference for the families and communities in her state. You can read a copy of the Resolution here. The resolution, offered Wednesday on what would have been Knutson’s 106th birthday, notes that after arriving in Washington, D.C in 1954, she convinced Speaker Sam Rayburn to appoint her to be the first woman ever to serve on the House
Klobuchar, Smith, Reed Call on Administration to Protect U.S. Troops and Families from Financial Fraud
WASHINGTON – U.S. Senators Amy Klobuchar and Tina Smith joined Senator Jack Reed (D-RI) and 46 other senators in calling on the Consumer Financial Protection Bureau (CFPB) to maintain financial protections for servicemembers and their families under the Military Lending Act (MLA). Recent reports have indicated that the Administration is planning to stop examining lenders for violations of the MLA. In their letter, the senators urged CFPB Acting Director Mick Mulvaney not to end its examinations of payday lenders and other financial institutions for MLA compliance, and to not undertake measures that risk leaving U.S. troops and their families vulnerable to exploitation.
U.S. Sen. Tina Smith Presses Swiss Pharmaceutical Giant Novartis to Ensure Improper Company Actions Aren’t Pushing Up U.S. Prescription Drug Prices
WASHINGTON D.C. [08/23/18]— Today, U.S. Sen. Tina Smith (D-Minn.) pushed for answers from Swiss pharmaceutical giant Novartis on improper financial and lobbying efforts – including a $1.2 million dollar payment to President Trump’s former lawyer Michael Cohen – that could be contributing to high prescription drug prices for people in Minnesota and across the country. In May, Novartis confirmed that it erred when it paid Cohen through a shell company to help influence Trump Administration health care policy. Those payments came after Novartis had already agreed in 2016 to comply with a U.S. Securities and Exchange Commission (SEC) order to establish
English